Visit Record of Dr. Chambers: December 9-11, 2024
In a discussion with Dr. Komiya, Director of the Women's Comprehensive Health Center, Dr. Chambers emphasized the importance of establishing specialized institutions for women's health in Japan. She hoped this initiative would foster more significant opportunities for international research collaboration. Women's health encompasses various issues, necessitating coordinated efforts among countries. Dr. Komiya also highlighted the importance of creating a platform where researchers and healthcare professionals from Japan and abroad can share expertise and promote pioneering initiatives.
During a lecture hosted by the J-TIS, Dr. Chambers stressed that collecting data on medication safety during pregnancy is essential. She pointed out that pregnancy registries are crucial for gathering such information. However, based on her experience in the U.S., she also acknowledged the challenges of establishing individual registries and emphasized the need for a more streamlined approach moving forward.
In a conversation with Dr. Yamaguchi, Director of the J-TIS, Dr. Chambers discussed the outlook for international data sharing. She underscored that this approach could lead to more effective collection and utilization of information on medication safety during pregnancy.
During visits to the Pharmaceutical Safety Division, Pharmaceutical and Food Safety Bureau, Ministry of Health, Labour and Welfare (MHLW), and the Pharmaceuticals and Medical Devices Agency (PMDA), recommendations emerged for establishing a command center at the Japan Drug Information Institute in Pregnancy, with administrative leadership playing a central role. This structure would support the smooth implementation of pregnancy registries in Japan.
